BLOG

Monday, October 29, 2018

Indian pharma to hit double-digit growth on US sales, weak rupee: CRISIL

As per Crisil, green shoots are already visible in the first quarter for 20 of these listed drug-makers

from Companies https://ift.tt/2SpYdEU
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...